RxDoctor Payments Data

Bethany Malott, PA

Family Medicine · Saginaw, MINPI 1215128962

Payments from drug & device makers

$7,923in general payments, 2019–2025

Across 462 payments — averaging $17.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$951
  • AstraZeneca$949
  • Lilly USA, LLC$800
  • Novo Nordisk$722
  • Pfizer$450
  • Amgen$406
  • plus $4K from 44 others

What the payments were for

  • Food & beverage$7,88199%
  • Education$421%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$7,923 in reported general payments places this provider in the 95th percentile of 3,945 family medicine providers in Michigan.

See all family medicine providers in Michigan

Medicare billing

Part B allowed, 2024
$57,078
Medicare patients
144
Services billed
1,187

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide125$183,035
EliquisApixaban132$117,943
JardianceEmpagliflozin90$111,926
Humira PenAdalimumab12$81,784
MounjaroTirzepatide59$72,517
Trelegy ElliptaFluticasone/Umeclidin/Vilanter48$57,511
JanuviaSitagliptin Phosphate21$28,245
LinzessLinaclotide25$25,017
TrulicityDulaglutide14$24,613
Victoza 3-PakLiraglutide13$24,202
RexultiBrexpiprazole13$22,539
XareltoRivaroxaban15$17,526
EntrestoSacubitril/Valsartan14$17,191
Breztri AerosphereBudesonide/Glycopyr/Formoterol17$14,598
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr17$12,697

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$722$183,035125 claims
PfizerEliquis, Paxlovid$450$123,441144 claims
Boehringer IngelheimJardiance$197$111,92690 claims
Lilly USA, LLCMounjaro, Trulicity$800$97,13073 claims
GSKTrelegy Ellipta, Anoro Ellipta$99$70,20865 claims
MerckJanuvia$155$28,24521 claims
AbbVieLinzess, Synthroid$951$27,81251 claims
AstraZenecaBreztri Aerosphere, Farxiga$949$25,17429 claims
Otsuka America Pharmaceutical, Inc.Rexulti$208$22,53913 claims
Johnson & JohnsonXarelto$165$17,52615 claims
NovartisEntresto$124$17,19114 claims
Astellas Pharma US IncMyrbetriq$150$12,39616 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,945 family medicine providers in Michigan.

Other family medicine in Saginaw

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →